Your browser doesn't support javascript.
loading
High p95HER2/HER2 Ratio Associated With Poor Outcome in Trastuzumab-Treated HER2-Positive Metastatic Breast Cancer NCCTG N0337 and NCCTG 98-32-52 (Alliance).
Chumsri, Saranya; Sperinde, Jeff; Liu, Heshan; Gligorov, Joseph; Spano, Jean-Philippe; Antoine, Martine; Moreno Aspitia, Alvaro; Tan, Winston; Winslow, John; Petropoulos, Christos J; Chenna, Ahmed; Bates, Michael; Weidler, Jodi Marie; Huang, Weidong; Dueck, Amylou; Perez, Edith A.
Afiliación
  • Chumsri S; Center for Breast Health, Mayo Clinic, Jacksonville, Florida. chumsri.saranya@mayo.edu.
  • Sperinde J; Monogram Biosciences, Inc., Laboratory Corporation of America Holdings, South San Francisco, California.
  • Liu H; Alliance Statistics and Data Center, Mayo Clinic, Rochester, Minnesota.
  • Gligorov J; Medical Oncology Department, APHP Tenon, Paris, France.
  • Spano JP; Pitié-Salpêtrière University Hospital, Paris, France.
  • Antoine M; Medical Oncology Department, APHP Tenon, Paris, France.
  • Moreno Aspitia A; Center for Breast Health, Mayo Clinic, Jacksonville, Florida.
  • Tan W; Center for Breast Health, Mayo Clinic, Jacksonville, Florida.
  • Winslow J; Monogram Biosciences, Inc., Laboratory Corporation of America Holdings, South San Francisco, California.
  • Petropoulos CJ; Monogram Biosciences, Inc., Laboratory Corporation of America Holdings, South San Francisco, California.
  • Chenna A; Monogram Biosciences, Inc., Laboratory Corporation of America Holdings, South San Francisco, California.
  • Bates M; Cepheid, Sunnyvale, California.
  • Weidler JM; Cepheid, Sunnyvale, California.
  • Huang W; Monogram Biosciences, Inc., Laboratory Corporation of America Holdings, South San Francisco, California.
  • Dueck A; Alliance Statistics and Data Center, Mayo Clinic, Scottsdale, Arizona.
  • Perez EA; Center for Breast Health, Mayo Clinic, Jacksonville, Florida.
Clin Cancer Res ; 24(13): 3053-3058, 2018 07 01.
Article en En | MEDLINE | ID: mdl-29530935
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Receptor ErbB-2 / Trastuzumab / Dominios Proteicos / Antineoplásicos Inmunológicos Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Middle aged Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2018 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Receptor ErbB-2 / Trastuzumab / Dominios Proteicos / Antineoplásicos Inmunológicos Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Middle aged Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2018 Tipo del documento: Article